Merck (MRK) Market Capitalization, Earnings, Price, Holders
Symbol: MRK Rank: #27 Price: $117.385(-0.70631%)

Market Cap: $297.8B($-2.1B) Industry: Drug Manufacturers General Sector: Healthcare Country: United States Insiders: 0.097% Institutions: 77.657%
Merck & Co., Inc. Technicals

52 Week High: $117.39

52 Week Low: $73.71

50 Day MA: $109.11

200 Day MA: $97.43

52 Week Trading Range


Low: $73.71

High: $117.39

Daily Trading Range


Low: $116.505

High: $118

Market capitalization history for Merck (MRK) in USD

As of November 2023, Merck (MRK) has a market cap of $297.8 billion. Our data points out that MRK is ranked #27 in the world. A company's market capitalization is the present value of all of its outstanding shares, and it is commonly used to give a sense of how much the stock of a company would be worth at today's exchange rates. MRK's market cap is -0.706309% down from the last trading day.

MRK Statistics

Market Cap
Revenue TTM
Gross Profit TTM
Operating Margin TTM
Shares Outstanding
Shares Float
Trading Volume
P/E Ratio
PEG Ratio
Revenue Per Share
Dividend Per Share
Dividend Yield
Quote Type
Leaf logo
CDP Climate Change Score (MRK)

Latest News

Merck (MRK) Shares Stats
Merck (MRK) Valuation
Trailing P/E $18.6754
Forward P/E $14.7493
Price Sales TTM $4.7132
Price Book MRQ $6.3616
Enterprise Value $301,993,420,899
Enterprise Value Revenue $5.1208
Enterprise Value Ebitda $13.9631
Merck & Co., Inc. Details

Address: 2000 Galloping Hill Road

City: Kenilworth

Zip: 07033

Phone: 908 740 4000


IPO Date: 1978-01-13

CEO: Kenneth C. Frazier

Employees: 67,000

What is MRK about?

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.